Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
MWN-AI** Summary
The Life Sciences Virtual Investor Forum is set to take place on March 11-12, 2026, offering a dynamic platform for individual and institutional investors, advisors, and analysts to engage with innovative companies in the life sciences sector. Hosted by Virtual Investor Conferences, this event encourages pre-registration, allowing participants to conduct online system checks for a smoother experience and receive crucial event updates.
The agenda showcases a variety of presentations from notable companies in the life sciences field. On March 11th, attendees will hear from organizations such as SeaStar Medical Holding Corporation (NASDAQ: ICU), Nasus Pharma Ltd. (NYSE: NSRX), and Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), among others. The following day, the schedule features presentations from Bora Pharmaceuticals Co., Ltd. (OTCQX: BORAY), Prostatype Genomics AB (OTCQB: PGABF), and Avicanna Inc. (OTCQX: AVCNF), to name a few. Each company will present valuable information on their strategies and innovations within the life sciences arena.
Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group, emphasized the importance of these events, stating that the Virtual Investor Conferences provide a crucial opportunity for companies to reach a wider audience and discuss their strategic initiatives. This forum not only allows live presentations but also facilitates one-on-one meetings between investors and management teams, enhancing direct communication.
For those interested in investor relations and networking opportunities, the full agenda and additional resources can be accessed at www.virtualinvestorconferences.com. The Life Sciences Virtual Investor Forum promises to be an impactful event, fostering connections and discussions that could shape future investments in the life sciences sector.
MWN-AI** Analysis
The upcoming Life Sciences Virtual Investor Forum on March 11-12, 2026, presents a valuable opportunity for investors looking to capitalize on emerging trends in the biotechnology and pharmaceutical sectors. With a diverse lineup of presentations from notable companies such as SeaStar Medical (NASDAQ: ICU), Tonix Pharmaceuticals (NASDAQ: TNXP), and Beyond Air (NASDAQ: XAIR), the forum is set to serve as a significant platform for assessing investment prospects.
Investors are encouraged to leverage this virtual format, which allows for direct interaction with management teams via scheduled one-on-one meetings. This element is particularly beneficial for gaining insights into company strategies, product pipelines, and long-term growth potential. Participating in these discussions can aid in evaluating the financial health and operational tactics of presenting companies.
Additionally, the forum showcases a range of enterprises from different niches within the life sciences sector, such as medical devices, genomics, and drug development. This diversity enhances the potential for investors to identify under-the-radar opportunities that may not yet have reached mainstream attention. Companies like EMVision Medical Devices (OTC: EMVDF) and Aethlon Medical (NASDAQ: AEMD) could provide breakthroughs in their respective fields, warranting a closer look.
As the biopharma sector continues to evolve, driven by innovations in personalized medicine and advanced therapeutics, staying informed about market movements and company advancements is critical. Participating in this forum may yield key insights that can influence investment decisions.
In conclusion, for investors keen on the life sciences realm, attending the Virtual Investor Forum may offer a unique vantage point to gauge promising companies and align their portfolios with emerging industry trends. Pre-registering ensures access to valuable information and engagement opportunities that could inform future investment strategies.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place March 11–12, 2026.
Individual investors, institutional investors, advisors, and analysts are invited to attend.
Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams.
Schedule 1x1 meetings here
“We are delighted to highlight today’s innovators from the Life Science sector,” said Jason Paltrowitz, EVP of Corporate Services at OTC Markets Group. “Our Virtual Investor Conferences continue to provide an efficient platform and unique opportunity for these companies to engage to a broader investor base and communicate their strategies.”
March 11th
| Eastern Time (ET) | Presentation | Ticker(s) |
| 12:00 PM | SeaStar Medical Holding Corporation | (NASDAQ: ICU) |
| 12:30 PM | Nasus Pharma Ltd. | (NYSE: NSRX) |
| 1:00 PM | Tonix Pharmaceuticals Holding Corp. | (NASDAQ: TNXP) |
| 1:30 PM | Jupiter Neurosciences, Inc. | (NASDAQ: JUNS) |
March 12th
| Eastern Time (ET) | Presentation | Ticker(s) |
| 09:30 AM | Bora Pharmaceuticals Co., Ltd. | (OTCQX: BORAY | TWSE: 6472) |
| 10:00 AM | Prostatype Genomics AB | (OTCQB: PGABF | NASDAQ Stockholm: PROGEN) |
| 10:30 AM | MetaVia Inc. | (NASDAQ: MTVA) |
| 11:00 AM | Phio Pharmaceuticals Corp. | (NASDAQ: PHIO) |
| 11:30 AM | Avicanna Inc. | (OTCQX: AVCNF | TSX: AVCN) |
| 12:00 PM | EMVision Medical Devices Ltd. | (OTC: EMVDF | ASX: EMV) |
| 1:00 PM | Aethlon Medical, Inc. | (NASDAQ: AEMD) |
| 1:30 PM | Dyadic International, Inc. | (NASDAQ: DYAI) |
| 2:00 PM | Jaguar Health, Inc. | (NASDAQ: JAGX) |
| 2:30 PM | Beyond Air, Inc. | (NASDAQ: XAIR) |
| 3:00 PM | Cadrenal Therapeutics, Inc. | (NASDAQ: CVKD) |
| 3:30 PM | Amplia Therapeutics Ltd. | (OTCQB: INNMF | ASX: ATX) |
To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com
Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com
FAQ**
What are the key innovations presented by Dyadic International Inc. (NASDAQ: DYAI) during the Virtual Investor Forum, and how do they impact the life sciences sector?
2. Can investors expect any updates on Dyadic International Inc. (DYAI) regarding their pipeline and upcoming clinical trials at the conference?
3. How does Dyadic International Inc. (NASDAQ: DYAI) plan to leverage its participation in the Virtual Investor Forum to attract new investors?
4. What are the anticipated financial projections for Dyadic International Inc. (DYAI) as discussed during their presentation at the Life Sciences Virtual Investor Forum?
**MWN-AI FAQ is based on asking OpenAI questions about MetaVia Inc Com Par $0.001 (NASDAQ: MTVA).
NASDAQ: MTVA
MTVA Trading
-1.72% G/L:
$1.5675 Last:
30,922 Volume:
$1.50 Open:
